Natural Polymeric Nanobiocomposites for Anti-Cancer Drug Delivery Therapeutics: A Recent Update

Overview

Journal Pharmaceutics

Publisher MDPI

Date 2023 Aug 26

PMID 37631276

Authors

Arijit Mondal

Amit Kumar Nayak

Prithviraj Chakraborty

Sabyasachi Banerjee

Bankim Chandra Nandy

Affiliations

Soon will be listed here.

Abstract

Cancer is one of the most common lethal diseases and the leading cause of mortality worldwide. Effective cancer treatment is a global problem, and subsequent advancements in nanomedicine are useful as substitute management for anti-cancer agents. Nanotechnology, which is gaining popularity, enables fast-expanding delivery methods in science for curing diseases in a site-specific approach, utilizing natural bioactive substances because several studies have established that natural plant-based bioactive compounds can improve the effectiveness of chemotherapy. Bioactive, in combination with nanotechnology, is an exceptionally alluring and recent development in the fight against cancer. Along with their nutritional advantages, natural bioactive chemicals may be used as chemotherapeutic medications to manage cancer. Alginate, starch, xanthan gum, pectin, guar gum, hyaluronic acid, gelatin, albumin, collagen, cellulose, chitosan, and other biopolymers have been employed successfully in the delivery of medicinal products to particular sites. Due to their biodegradability, natural polymeric nanobiocomposites have garnered much interest in developing novel anti-cancer drug delivery methods. There are several techniques to create biopolymer-based nanoparticle systems. However, these systems must be created in an affordable and environmentally sustainable way to be more readily available, selective, and less hazardous to increase treatment effectiveness. Thus, an extensive comprehension of the various facets and recent developments in natural polymeric nanobiocomposites utilized to deliver anti-cancer drugs is imperative. The present article provides an overview of the latest research and developments in natural polymeric nanobiocomposites, particularly emphasizing their applications in the controlled and targeted delivery of anti-cancer drugs.

Citing Articles

Cancer theragnostics: closing the loop for advanced personalized cancer treatment through the platform integration of therapeutics and diagnostics.

Sergeeva O, Luo L, Guiseppi-Elie A Front Bioeng Biotechnol. 2025; 12:1499474.

PMID: 39898278 PMC: 11782185. DOI: 10.3389/fbioe.2024.1499474.

Advanced functional Cu-Cr-Co-NPs@gelatin (GLN)-hydroxyethyl cellulose (HEC) nanocomposites with antimicrobial and anticancer activities.

Hasanin M, Saeb M, Abdel-Maksou M, El-Tayeb M, Kiani B, Hashem A RSC Adv. 2024; 14(50):37633-37643.

PMID: 39588241 PMC: 11587289. DOI: 10.1039/d4ra06216g.

Radiation-induced nanogel engineering based on pectin for pH-responsive rutin delivery for cancer treatment.

El-Adl K, Ghobashy M, Ismail A, El-Morsy A, Shoman N Naunyn Schmiedebergs Arch Pharmacol. 2024; .

PMID: 39540896 DOI: 10.1007/s00210-024-03573-y.

A cutting-edge new framework for the pain management in children: nanotechnology.

Starcea I, Lupu A, Nistor A, Mocanu M, Bogos R, Azoicai A Front Mol Neurosci. 2024; 17:1391092.

PMID: 39318422 PMC: 11420925. DOI: 10.3389/fnmol.2024.1391092.

Smart delivery vehicles for cancer: categories, unique roles and therapeutic strategies.

Zeng Y, Gao Y, He L, Ge W, Wang X, Ma T Nanoscale Adv. 2024; 6(17):4275-4308.

PMID: 39170969 PMC: 11334973. DOI: 10.1039/d4na00285g.

References

Luo D, Carter K, Miranda D, Lovell J . Chemophototherapy: An Emerging Treatment Option for Solid Tumors. Adv Sci (Weinh). 2017; 4(1):1600106. PMC: 5238751. DOI: 10.1002/advs.201600106. View

Kim J . Categorizing accident sequences in the external radiotherapy for risk analysis. Radiat Oncol J. 2013; 31(2):88-96. PMC: 3712178. DOI: 10.3857/roj.2013.31.2.88. View

Madusanka N, de Silva K, Amaratunga G . A curcumin activated carboxymethyl cellulose-montmorillonite clay nanocomposite having enhanced curcumin release in aqueous media. Carbohydr Polym. 2015; 134:695-9. DOI: 10.1016/j.carbpol.2015.08.030. View

Tsakiris N, Papavasileiou M, Bozzato E, Lopes A, Vigneron A, Preat V . Combinational drug-loaded lipid nanocapsules for the treatment of cancer. Int J Pharm. 2019; 569:118588. DOI: 10.1016/j.ijpharm.2019.118588. View

Ates B, Koytepe S, Ulu A, Gurses C, Thakur V . Chemistry, Structures, and Advanced Applications of Nanocomposites from Biorenewable Resources. Chem Rev. 2020; 120(17):9304-9362. DOI: 10.1021/acs.chemrev.9b00553. View

Mostafavi E, Medina-Cruz D, Kalantari K, Taymoori A, Soltantabar P, Webster T . Electroconductive Nanobiomaterials for Tissue Engineering and Regenerative Medicine. Bioelectricity. 2021; 2(2):120-149. PMC: 8370325. DOI: 10.1089/bioe.2020.0021. View

Bao H, Pan Y, Ping Y, Sahoo N, Wu T, Li L . Chitosan-functionalized graphene oxide as a nanocarrier for drug and gene delivery. Small. 2011; 7(11):1569-78. DOI: 10.1002/smll.201100191. View

Ramakrishnan R, Gabrilovich D . Novel mechanism of synergistic effects of conventional chemotherapy and immune therapy of cancer. Cancer Immunol Immunother. 2013; 62(3):405-10. PMC: 11029489. DOI: 10.1007/s00262-012-1390-6. View

Raafat D, Sahl H . Chitosan and its antimicrobial potential--a critical literature survey. Microb Biotechnol. 2011; 2(2):186-201. PMC: 3815839. DOI: 10.1111/j.1751-7915.2008.00080.x. View

10.

Massoumi B, Mozaffari Z, Jaymand M . A starch-based stimuli-responsive magnetite nanohydrogel as de novo drug delivery system. Int J Biol Macromol. 2018; 117:418-426. DOI: 10.1016/j.ijbiomac.2018.05.211. View

11.

George D, Maheswari P, Sheriffa Begum K, Arthanareeswaran G . Biomass-Derived Dialdehyde Cellulose Cross-linked Chitosan-Based Nanocomposite Hydrogel with Phytosynthesized Zinc Oxide Nanoparticles for Enhanced Curcumin Delivery and Bioactivity. J Agric Food Chem. 2019; 67(39):10880-10890. DOI: 10.1021/acs.jafc.9b01933. View

12.

Bae Y, Park K . Targeted drug delivery to tumors: myths, reality and possibility. J Control Release. 2011; 153(3):198-205. PMC: 3272876. DOI: 10.1016/j.jconrel.2011.06.001. View

13.

Ignjatovic N, Penov-Gasi K, Ajdukovic J, Kojic V, Markovic S, Uskokovic D . The effect of the androstane lung cancer inhibitor content on the cell-selective toxicity of hydroxyapatite-chitosan-PLGA nanocomposites. Mater Sci Eng C Mater Biol Appl. 2018; 89:371-377. DOI: 10.1016/j.msec.2018.04.028. View

14.

Bose S, Banerjee S, Mondal A, Chakraborty U, Pumarol J, Croley C . Targeting the JAK/STAT Signaling Pathway Using Phytocompounds for Cancer Prevention and Therapy. Cells. 2020; 9(6). PMC: 7348822. DOI: 10.3390/cells9061451. View

15.

Zhang K, Ma B, Hu K, Yuan B, Sun X, Song X . Evidence-based biomaterials research. Bioact Mater. 2022; 15:495-503. PMC: 9122837. DOI: 10.1016/j.bioactmat.2022.04.014. View

16.

Trindade I, Pound-Lana G, Pereira D, de Oliveira L, Andrade M, Vilela J . Mechanisms of interaction of biodegradable polyester nanocapsules with non-phagocytic cells. Eur J Pharm Sci. 2018; 124:89-104. DOI: 10.1016/j.ejps.2018.08.024. View

17.

Rasoulzadeh M, Namazi H . Carboxymethyl cellulose/graphene oxide bio-nanocomposite hydrogel beads as anticancer drug carrier agent. Carbohydr Polym. 2017; 168:320-326. DOI: 10.1016/j.carbpol.2017.03.014. View

18.

Wang J, Sui L, Huang J, Miao L, Nie Y, Wang K . MoS-based nanocomposites for cancer diagnosis and therapy. Bioact Mater. 2021; 6(11):4209-4242. PMC: 8102209. DOI: 10.1016/j.bioactmat.2021.04.021. View

19.

Das R, Kasoju N, Bora U . Encapsulation of curcumin in alginate-chitosan-pluronic composite nanoparticles for delivery to cancer cells. Nanomedicine. 2009; 6(1):153-60. DOI: 10.1016/j.nano.2009.05.009. View

20.

Raval N, Mistry T, Acharya N, Acharya S . Development of glutathione-conjugated asiatic acid-loaded bovine serum albumin nanoparticles for brain-targeted drug delivery. J Pharm Pharmacol. 2015; 67(11):1503-11. DOI: 10.1111/jphp.12460. View